ArticlePharmaceutics2021

Evaluation of an Intravitreal Rho-Associated Kinase Inhibitor Depot Formulation in a Rat Model of Diabetic Retinopathy.

Cecile Lebon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.